Literature DB >> 32276277

Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.

Sara Calzavarini1,2, Raja Prince-Eladnani1,2, François Saller3, Luca Bologna1,2, Laurent Burnier4, Anne C Brisset5, Claudia Quarroz1,2, Maria Desiré Reina Caro1,2, Vladimir Ermolayev6, Yasuhiro Matsumura7, José A Fernández4, Tilman M Hackeng8, John H Griffin4, Anne Angelillo-Scherrer1,2.   

Abstract

Anticoagulant protein S (PS) in platelets (PSplt) resembles plasma PS and is released on platelet activation, but its role in thrombosis has not been elucidated. Here we report that inactivation of PSplt expression using the Platelet factor 4 (Pf4)-Cre transgene (Pros1lox/loxPf4-Cre+) in mice promotes thrombus propensity in the vena cava, where shear rates are low, but not in the carotid artery, where shear rates are high. At a low shear rate, PSplt functions as a cofactor for both activated protein C and tissue factor pathway inhibitor, thereby limiting factor X activation and thrombin generation within the growing thrombus and ensuring that highly activated platelets and fibrin remain localized at the injury site. In the presence of high thrombin concentrations, clots from Pros1lox/loxPf4-Cre- mice contract, but not clots from Pros1lox/loxPf4-Cre+ mice, because of highly dense fibrin networks. Thus, PSplt controls platelet activation as well as coagulation in thrombi in large veins, but not in large arteries.
© 2020 by The American Society of Hematology.

Entities:  

Year:  2020        PMID: 32276277      PMCID: PMC7256357          DOI: 10.1182/blood.2019003630

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin.

Authors:  J H Griffin; A Gruber; J A Fernández
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

2.  Protection against thrombosis in mice lacking PAR3.

Authors:  Ethan J Weiss; Justin R Hamilton; Katy E Lease; Shaun R Coughlin
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

3.  Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo.

Authors:  Ralph Tiedt; Tibor Schomber; Hui Hao-Shen; Radek C Skoda
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

4.  Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature.

Authors:  J D Welsh; I Poventud-Fuentes; S Sampietro; S L Diamond; T J Stalker; L F Brass
Journal:  J Thromb Haemost       Date:  2017-02-06       Impact factor: 5.824

5.  Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).

Authors:  C Y Vossen; J Conard; J Fontcuberta; M Makris; F J M VAN DER Meer; I Pabinger; G Palareti; F E Preston; I Scharrer; J C Souto; P Svensson; I D Walker; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

6.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

7.  Dissociation of activated protein C functions by elimination of protein S cofactor enhancement.

Authors:  Shona Harmon; Roger J S Preston; Fionnuala Ni Ainle; Jennifer A Johnson; Moya S Cunningham; Owen P Smith; Barry White; James S O'Donnell
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

8.  Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)

Authors:  T Koster; F R Rosendaal; E Briët; F J van der Meer; L P Colly; P H Trienekens; S R Poort; P H Reitsma; J P Vandenbroucke
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

9.  Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation.

Authors:  Julia Novotny; Sue Chandraratne; Tobias Weinberger; Vanessa Philippi; Konstantin Stark; Andreas Ehrlich; Joachim Pircher; Ildiko Konrad; Paul Oberdieck; Anna Titova; Qendresa Hoti; Irene Schubert; Kyle R Legate; Nicole Urtz; Michael Lorenz; Jaroslav Pelisek; Steffen Massberg; Marie-Luise von Brühl; Christian Schulz
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

Review 10.  Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography.

Authors:  Cristina Solomon; Marco Ranucci; Gerald Hochleitner; Herbert Schöchl; Christoph J Schlimp
Journal:  Anesth Analg       Date:  2015-10       Impact factor: 6.627

View more
  7 in total

1.  Regulation of venous thrombosis by platelet protein S.

Authors:  Rinku Majumder
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

2.  Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity.

Authors:  Jocelyn A Schroeder; Juan Chen; Yingyu Chen; Yuanhua Cai; Hongyin Yu; Jeremy G Mattson; Paul E Monahan; Qizhen Shi
Journal:  Blood Adv       Date:  2021-03-09

3.  Platelet anticoagulant proteins: Modulators of thrombosis propensity within a procoagulant cell.

Authors:  Amy E Siebert; Alan E Mast
Journal:  J Thromb Haemost       Date:  2020-07-30       Impact factor: 5.824

4.  Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

Authors:  Adrienn Teraz-Orosz; Magdalena Gierula; Anastasis Petri; David Jones; Renos Keniyopoullos; Patricia Badia Folgado; Salvatore Santamaria; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood Adv       Date:  2022-01-25

5.  Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow.

Authors:  Sanne L N Brouns; Bibian M E Tullemans; Cristiana Bulato; Gina Perrella; Elena Campello; Luca Spiezia; Johanna P van Geffen; Marijke J E Kuijpers; René van Oerle; Henri M H Spronk; Paola E J van der Meijden; Paolo Simioni; Johan W M Heemskerk
Journal:  Res Pract Thromb Haemost       Date:  2022-03-07

6.  The contribution of TFPIα to the hemostatic response to injury in mice.

Authors:  Tanya T Marar; Nicholas D Martinez; Susan A Maroney; Amy E Siebert; Jie Wu; Timothy J Stalker; Maurizio Tomaiuolo; Sinny Delacroix; Robert D Simari; Alan E Mast; Lawrence F Brass
Journal:  J Thromb Haemost       Date:  2021-07-14       Impact factor: 16.036

Review 7.  Protein S: function, regulation, and clinical perspectives.

Authors:  Rinku Majumder; Tina Nguyen
Journal:  Curr Opin Hematol       Date:  2021-09-01       Impact factor: 3.218

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.